Abiopharma

🔍 Whitehurst Bradford D. (Director)

Company: USA Compression Partners, LP (USAC)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 4,000 shares of Common Units at $26.4 per share (Direct)
  Date: 2026-08-20 | Code: P | equity_swap_involved: 0 | shares_owned_after: 37,616.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 6,000 shares of Common Units at $26.1 per share (Direct)
  Date: 2026-08-21 | Code: P | equity_swap_involved: 0 | shares_owned_after: 43,616.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Includes common units acquired under the Distribution Reinvestment Plan of USA Compression Partners, LP (the "Issuer").
• REMARKS: The Reporting Person is a director of USA Compression GP, LLC, the general partner of the Issuer (the "General Partner"). The Issuer is managed by the directors and executive officers of the General Partner.